Terpos, Evangelos http://orcid.org/0000-0001-5133-1422
Musto, Pellegrino http://orcid.org/0000-0003-3277-6594
Engelhardt, Monika http://orcid.org/0000-0003-0405-1676
Delforge, Michel
Cook, Gordon http://orcid.org/0000-0003-1717-0412
Gay, Francesca http://orcid.org/0000-0002-8619-412X
van de Donk, Niels W. C. J.
Ntanasis-Stathopoulos, Ioannis http://orcid.org/0000-0002-6328-9783
Vangsted, Annette Juul http://orcid.org/0000-0002-2131-731X
Driessen, Christoph
Schjesvold, Fredrik http://orcid.org/0000-0003-1096-0569
Cerchione, Claudio http://orcid.org/0000-0002-9104-5436
Zweegman, Sonja
Hajek, Roman http://orcid.org/0000-0001-6955-6267
Moreau, Philippe http://orcid.org/0000-0003-1780-8746
Einsele, Hermann http://orcid.org/0000-0002-7680-0819
San-Miguel, Jesus http://orcid.org/0000-0002-9183-4857
Boccadoro, Mario http://orcid.org/0000-0001-8130-5209
Dimopoulos, Meletios A. http://orcid.org/0000-0001-8990-3254
Sonneveld, Pieter http://orcid.org/0000-0002-0808-2237
Ludwig, Heinz http://orcid.org/0000-0002-3302-8726
Article History
Received: 17 April 2023
Revised: 19 April 2023
Accepted: 21 April 2023
First Online: 4 May 2023
Competing interests
: Evangelos Terpos declares honoraria for advisory boards or lectures from Amgen, Astra/Zeneca, Bristol Myers Squibb, Eusa Pharma, GSK, Integris Pharma, Janssen, Pfizer, Sanofi and Takeda; research support (to institution) from Amgen, GSK, Janssen, Sanofi and Takeda; travel grants from Amgen, Eusa Pharma and Takeda. Pellegrino Musto declares honoraria for advisory boards or lectures from Celgene, Janssen-Cilag, Takeda, Amgen, BMS, Sanofi, Abbvie, Pfizer, Seattle Genetics and research support from Amgen, Sanofi. FG has received honoraria from Amgen, Celgene, Janssen, Takeda, Bristol Myers Squibb, AbbVie, and GlaxoSmithKline; has served on the advisory boards for Amgen, Celgene, Janssen, Takeda, Bristol Myers Squibb, AbbVie, GlaxoSmithKline, Roche, Adaptive Biotechnologies, Oncopeptides, bluebird bio, and Pfizer. NWCJD has received research support from Janssen Pharmaceuticals, AMGEN, Celgene, Novartis, Cellectis and BMS, and serves in advisory boards for Janssen Pharmaceuticals, AMGEN, Celgene, BMS, Takeda, Roche, Novartis, and Adaptive, all paid to institution. FS has received Grants from Celgene, Janssen, Oncopeptides, Sanofi, GSK, Targovax, Honoraria from Amgen, BMS, Takeda, Abbvie, Janssen, Novartis, SkyliteDX, Oncopeptides, Sanofi, Pfizer, Daiki-Sankyo, GSK, and Honoraria from participation in advisory boards for Abbvie, GSK, Celgene, Takeda, Janssen, Oncopeptides, Sanofi, BMS. CC declares Advisory board e/o speaker for Abbvie, AMGEN, Astellas, Beigene, BMS, Glycomimetics, GSK, Immunogen, Janssen, Jazz, Karyopharm, Menarini, Oncopeptides, Pfizer, Sanofi, Servier, Stemline, Takeda. Roman Hajek has had a consultant or advisory relationship with Janssen, Amgen, Celgene, AbbVie, BMS, Novartis, PharmaMar, and Takeda; has received honoraria from Janssen, Amgen, Celgene, BMS, PharmaMar, and Takeda; has received research funding from Janssen, Amgen, Celgene, BMS, Novartis, and Takeda. PM declares honoraria and advisory boards from janssen, celgene, takeda, amgen, abbvie, Sanofi. Hermann Einsele declares Consulting or Advisory Role for BMS/Celgene, Janssen, Amgen, Takeda, Sanofi, GSK, Novartis, Research Funding from BMS/Celgene, Janssen, Amgen, GSK, Sanofi, Honoraria from BMS/Celgene, Janssen, Amgen, Takeda, Sanofi, GSK, Novartis, and Travel Support from BMS/Celgene, Janssen, Amgen, Takeda, Novartis, Sanofi. JS-M declares advisory boards and consulting services, on behalf of my Institution, for Abbvie, Amgen, BMS, Celgene, GSK, Haemalogix, Janssen-Cilag, Karyopharm, MSD, Novartis, Pfizer, Takeda, Regeneron, Roche, Sanofi, and SecuraBio. MB has received honoraria from Sanofi, Celgene, Amgen, Janssen, Novartis, Bristol Myers Squibb, and AbbVie; has served on the advisory boards for Janssen and GlaxoSmithKline; has received research funding from Sanofi, Celgene, Amgen, Janssen, Novartis, Bristol Myers Squibb, and Mundipharma. MAD declares honoraria from participation in Advisory Boards from Amgen, Takeda, BMS, Janssen, Beigene, Sanofi. PS declares research support from Amgen, BMS, Janssen, Sanofi, participation in Advisory Boards for Amgen, BMS, Janssen, Sanofi, Pfizer, Seagen, Karyopharm, Oncopeptides. HL declares research support from Amgen, Sanofi and honoraria for advisory boards/lectures from Celgene-BMS, Janssen-Cilag, Takeda, Amgen, Sanofi, Seattle Genetics, AbbVie, Pfizer, Oncopeptides. All other authors declare no conflicts of interest related to this paper.
Free to read: This content has been made available to all.